Asad Hader

“A couple of big-picture questions for Chris. First, just on PD, given this remains a top capital allocation priority, Would be curious to hear any updated thoughts on how you're thinking about ideal stage of development, therapeutic area, deal structures, and even transformative deals.”

“On the double-digit growth by the end of the decade, the vocabulary in the press release references the progress in the underlying business, quote, together with strategic investments.”

“For Albert or Cecile, just back to COVID, just given that the trend has continued to be lower than expected and understanding that the lowered $4 billion for 2026 is somewhat secured by contracts and your expectations for vaccination rates, just curious as to what you're expecting in terms of the long-term trajectory…”

“Albert, just going back to last December's guidance goal, you highlighted $17 billion of annual revenue impacted by LOEs by 2030.”

“First, Rob, just maybe for you, in the context of the statements that you continue to see upside to consensus forecasts for both SkyRisi and WinVoke going out each year and that upside growing each year, just curious as to how that triangulates with your calculus of no longer updating midterm guidance for these…”